Conference Reports for NATAP
5th International Workshop on Hepatitis C
Resistance and New Compounds
24-25 June 2010, Boston, MA USA
HCV NS5A Targeted Antivirals (BMS-790052)
Boston --June 24 & 25, 2010, HCV Drug Resistance New Compounds Workshop
Department of Infectious Disease
Bristol--Myers Squibb Research Myers Research
Once-daily NS5A Inhibitor (BMS-790052) Plus Peginterferon-alpha-2a ...
Apr 17, 2010 ... Once-daily NS5A Inhibitor (BMS-790052) Plus Peginterferon-alpha-2a And Ribavirin Produces High Rates Of Extended Rapid Virologic Response In ...
BMS NS5A HCV Inhibitor - chemical genetics discovery process in ...
Here we describe the profile of BMS-790052, a small molecule inhibitor of the HCV NS5A protein that exhibits picomolar half-maximum effective concentrations ...